Brian VanderBeek, MD, MPH, MSCE

faculty photo
Associate Professor of Ophthalmology at the Hospital of the University of Pennsylvania
Department: Ophthalmology

Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
Education:
BA (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
MPH (Toxicology)
University of Michigan, School of Public Health, 2001.
MD
University of Cincinnati College of Medicine, 2005.
MSCE
University of Pennsylvania School of Medicine, 2015.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Diabetic Retinopathy
Age-related Macular Degeneration
Retinal Vein Occlusion

Description of Research Expertise

Epidemiology
Observational study design
Big data analysis

Selected Publications

Ying GS, VanderBeek BL.: Radiotherapy for anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Lancet Jun 2024.

VanderBeek BL, Yu Y: Visual deficits due to diabetic retinal disease. Association for Research in Vision and Ophthalmology May 2024 Notes: Poster presentation.

VanderBeek BL, Yu Y, Stein JD : Visual deficits due to diabetic retinal disease. American Ophthalmology Society May 2024 Notes: poster presentation.

Tomaiuolo M, VanderBeek BL, Deaner JD, Syed ZA, Acharya B, Zhang Q, Schuman JS, Hyman L: Are Clinical Treatment Patterns for Endophthalmitis After Cataract Surgery Following the EVS Trial Recommendations? An Intelligent Research in Sight (IRIS)® Registry Analysis. Association for Research in Vision and Ophthalmology May 2024 Notes: poster presentation.

Randy Dotinga: No Difference in Kidney Failure Risk Between Three Anti-VEGF Agents for Eye Disease. MedPage Today Apr 2024 Notes: https://www.medpagetoday.com/ophthalmology/generalophthalmology/109592.

VanderBeek BL.: Toward Eliminating Visual Impairment Due to Refractive Error. JAMA Ophthalmol 142: 299-300, Apr 2024.

Papaliodis GN, Yu Y, Brill DA, Sobrin L, VanderBeek B.: Malignancy Risk Associated With the Use of Systemic Immunomodulatory Therapy in the Management of Noninfectious Uveitis. Am J Ophthalmol 265: 241-247, Apr 2024.

Gupta AS, Yu Y, Orlin SE, VanderBeek BL.: Real-world socioeconomic determinants of corneal crosslinking in a national cohort. J Cataract Refract Surg 50: 217-223, Mar 2024.

VanderBeek BL, Yu Y, Oden N, VanVeldhuisen P, Blodi B, Ip M, Scott IU. : Visit Adherence and Visual Acuity in Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2). Ophthalmic Epidemiol 31(1): 78-83, Feb 2024.

Wang SY, Ravindranath R, Stein JD; SOURCE Consortium.: Prediction Models for Glaucoma in a Multicenter Electronic Health Records Consortium: The Sight Outcomes Research Collaborative. Ophthalmol Sci 4: 100445, Dec 2023.

back to top
Last updated: 06/18/2024
The Trustees of the University of Pennsylvania